Tag: Nanotechnology
-
Imagion Biosystems receives FDA breakthrough designation for breast cancer detection device
Imagion Biosystems (ASX: IBX) has received notification from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) that the MagSense System and Test for staging HER2 breast cancer had qualified for and been granted designation as a... Read More